Offer - Urjas Oil for just ₹ 1 X
Alrubicin 150 Injection, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Breast Cancer.
The optimal dosage of Alrubicin 150 Injection is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
While these are the most often observed Alrubicin 150 Injection side effects, there are can be others also. These have been listed below. Such side effects of Alrubicin 150 Injection normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Alrubicin 150 Injection's effect is Severe during pregnancy and Severe for lactating mothers. Further, the section on Alrubicin 150 Injection related warnings talks about Alrubicin 150 Injection's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Alrubicin 150 Injection contraindications section.
Besides this, Alrubicin 150 Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Alrubicin 150 Injection is not safe while driving, and is is not addictive in nature.
Alrubicin 150 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Is the use of Alrubicin 150 Injection safe for pregnant women?
Alrubicin should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Alrubicin 150 Injection safe during breastfeeding?
Taking Alrubicin may lead to serious side effects if you are breastfeeding. Alrubicin should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Alrubicin 150 Injection on the Kidneys?
Kidney can be affected by Alrubicin. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Alrubicin 150 Injection on the Liver?
Alrubicin may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Alrubicin 150 Injection on the Heart?
Alrubicin can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Alrubicin 150 Injection unless your doctor advises you to do so -
Is this Alrubicin 150 Injection habit forming or addictive?
Alrubicin 150 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Alrubicin 150 Injection, you should not drive or work on any heavy machine, as Alrubicin 150 Injection can make you drowsy.
Is it safe?
Yes, but take Alrubicin 150 Injection only as per medical advice.
Is it able to treat mental disorders?
No, the use of Alrubicin 150 Injection in mental disorders is not effective.
Interaction between Food and Alrubicin 150 Injection
Taking Alrubicin 150 Injection with food does not harm your health.
Interaction between Alcohol and Alrubicin 150 Injection
Taking alcohol with Alrubicin 150 Injection can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ellence® (epirubicin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 867
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 505-508